173 related articles for article (PubMed ID: 35395177)
21. Analysis of alternative lengthening of telomere markers in BRCA1 defective cells.
Kargaran PK; Yasaei H; Anjomani-Virmouni S; Mangiapane G; Slijepcevic P
Genes Chromosomes Cancer; 2016 Nov; 55(11):864-76. PubMed ID: 27295426
[TBL] [Abstract][Full Text] [Related]
22. TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT.
de Nonneville A; Salas S; Bertucci F; Sobinoff AP; Adélaïde J; Guille A; Finetti P; Noble JR; Churikov D; Chaffanet M; Lavit E; Pickett HA; Bouvier C; Birnbaum D; Reddel RR; Géli V
EMBO Mol Med; 2022 Oct; 14(10):e15859. PubMed ID: 35920001
[TBL] [Abstract][Full Text] [Related]
23. Compromised Telomeric Heterochromatin Promotes ALTernative Lengthening of Telomeres.
Voon HPJ; Collas P; Wong LH
Trends Cancer; 2016 Mar; 2(3):114-116. PubMed ID: 28741530
[TBL] [Abstract][Full Text] [Related]
24. Leiomyosarcoma with alternative lengthening of telomeres is associated with aggressive histologic features, loss of ATRX expression, and poor clinical outcome.
Liau JY; Tsai JH; Jeng YM; Lee JC; Hsu HH; Yang CY
Am J Surg Pathol; 2015 Feb; 39(2):236-44. PubMed ID: 25229770
[TBL] [Abstract][Full Text] [Related]
25. Alternative lengthening of telomeres and ATRX/DAXX loss can be reliably detected in FNAs of pancreatic neuroendocrine tumors.
VandenBussche CJ; Allison DB; Graham MK; Charu V; Lennon AM; Wolfgang CL; Hruban RH; Heaphy CM
Cancer Cytopathol; 2017 Jul; 125(7):544-551. PubMed ID: 28371511
[TBL] [Abstract][Full Text] [Related]
26. Feeders facilitate telomere maintenance and chromosomal stability of embryonic stem cells.
Guo R; Ye X; Yang J; Zhou Z; Tian C; Wang H; Wang H; Fu H; Liu C; Zeng M; Yang J; Liu L
Nat Commun; 2018 Jul; 9(1):2620. PubMed ID: 29976922
[TBL] [Abstract][Full Text] [Related]
27. Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation.
Ferreira MSV; Sørensen MD; Pusch S; Beier D; Bouillon AS; Kristensen BW; Brümmendorf TH; Beier CP; Beier F
J Neurooncol; 2020 Mar; 147(1):1-14. PubMed ID: 31960234
[TBL] [Abstract][Full Text] [Related]
28. Extrachromosomal telomere repeat DNA is linked to ALT development via cGAS-STING DNA sensing pathway.
Chen YA; Shen YL; Hsia HY; Tiang YP; Sung TL; Chen LY
Nat Struct Mol Biol; 2017 Dec; 24(12):1124-1131. PubMed ID: 29106411
[TBL] [Abstract][Full Text] [Related]
29. Telomeres reforged with non-telomeric sequences in mouse embryonic stem cells.
Kim C; Sung S; Kim JS; Lee H; Jung Y; Shin S; Kim E; Seo JJ; Kim J; Kim D; Niida H; Kim VN; Park D; Lee J
Nat Commun; 2021 Feb; 12(1):1097. PubMed ID: 33597549
[TBL] [Abstract][Full Text] [Related]
30. Alternative lengthening of telomeres does exist in various canine sarcomas.
Kreilmeier T; Sampl S; Deloria AJ; Walter I; Reifinger M; Hauck M; Borst LB; Holzmann K; Kleiter M
Mol Carcinog; 2017 Mar; 56(3):923-935. PubMed ID: 27585244
[TBL] [Abstract][Full Text] [Related]
31. The PML-associated protein DEK regulates the balance of H3.3 loading on chromatin and is important for telomere integrity.
Ivanauskiene K; Delbarre E; McGhie JD; Küntziger T; Wong LH; Collas P
Genome Res; 2014 Oct; 24(10):1584-94. PubMed ID: 25049225
[TBL] [Abstract][Full Text] [Related]
32. The chromatin remodelling factor ATRX suppresses R-loops in transcribed telomeric repeats.
Nguyen DT; Voon HPJ; Xella B; Scott C; Clynes D; Babbs C; Ayyub H; Kerry J; Sharpe JA; Sloane-Stanley JA; Butler S; Fisher CA; Gray NE; Jenuwein T; Higgs DR; Gibbons RJ
EMBO Rep; 2017 Jun; 18(6):914-928. PubMed ID: 28487353
[TBL] [Abstract][Full Text] [Related]
33. Dcaf11 activates Zscan4-mediated alternative telomere lengthening in early embryos and embryonic stem cells.
Le R; Huang Y; Zhang Y; Wang H; Lin J; Dong Y; Li Z; Guo M; Kou X; Zhao Y; Chen M; Zhu Q; Zhao A; Yin J; Sun J; Su Z; Shi K; Gao Y; Chen J; Liu W; Kang L; Wang Y; Li C; Liu X; Gao R; Wang H; Ju Z; Gao S
Cell Stem Cell; 2021 Apr; 28(4):732-747.e9. PubMed ID: 33357405
[TBL] [Abstract][Full Text] [Related]
34. Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.
Lovejoy CA; Li W; Reisenweber S; Thongthip S; Bruno J; de Lange T; De S; Petrini JH; Sung PA; Jasin M; Rosenbluh J; Zwang Y; Weir BA; Hatton C; Ivanova E; Macconaill L; Hanna M; Hahn WC; Lue NF; Reddel RR; Jiao Y; Kinzler K; Vogelstein B; Papadopoulos N; Meeker AK;
PLoS Genet; 2012; 8(7):e1002772. PubMed ID: 22829774
[TBL] [Abstract][Full Text] [Related]
35. ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells.
Wong LH; McGhie JD; Sim M; Anderson MA; Ahn S; Hannan RD; George AJ; Morgan KA; Mann JR; Choo KH
Genome Res; 2010 Mar; 20(3):351-60. PubMed ID: 20110566
[TBL] [Abstract][Full Text] [Related]
36. Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency.
Han M; Napier CE; Frölich S; Teber E; Wong T; Noble JR; Choi EHY; Everett RD; Cesare AJ; Reddel RR
J Cell Sci; 2019 Mar; 132(5):. PubMed ID: 30745338
[TBL] [Abstract][Full Text] [Related]
37. Telomere length heterogeneity in ALT cells is maintained by PML-dependent localization of the BTR complex to telomeres.
Loe TK; Li JSZ; Zhang Y; Azeroglu B; Boddy MN; Denchi EL
Genes Dev; 2020 May; 34(9-10):650-662. PubMed ID: 32217664
[TBL] [Abstract][Full Text] [Related]
38. Rapid and reversible suppression of ALT by DAXX in osteosarcoma cells.
Yost KE; Clatterbuck Soper SF; Walker RL; Pineda MA; Zhu YJ; Ester CD; Showman S; Roschke AV; Waterfall JJ; Meltzer PS
Sci Rep; 2019 Mar; 9(1):4544. PubMed ID: 30872698
[TBL] [Abstract][Full Text] [Related]
39. Telomere length alterations and ATRX/DAXX loss in pituitary adenomas.
Heaphy CM; Bi WL; Coy S; Davis C; Gallia GL; Santagata S; Rodriguez FJ
Mod Pathol; 2020 Aug; 33(8):1475-1481. PubMed ID: 32203094
[TBL] [Abstract][Full Text] [Related]
40. Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size.
Hackeng WM; Brosens LAA; Kim JY; O'Sullivan R; Sung YN; Liu TC; Cao D; Heayn M; Brosnan-Cashman J; An S; Morsink FHM; Heidsma CM; Valk GD; Vriens MR; Nieveen van Dijkum E; Offerhaus GJA; Dreijerink KMA; Zeh H; Zureikat AH; Hogg M; Lee K; Geller D; Marsh JW; Paniccia A; Ongchin M; Pingpank JF; Bahary N; Aijazi M; Brand R; Chennat J; Das R; Fasanella KE; Khalid A; McGrath K; Sarkaria S; Singh H; Slivka A; Nalesnik M; Han X; Nikiforova MN; Lawlor RT; Mafficini A; Rusev B; Corbo V; Luchini C; Bersani S; Pea A; Cingarlini S; Landoni L; Salvia R; Milione M; Milella M; Scarpa A; Hong SM; Heaphy CM; Singhi AD
Gut; 2022 May; 71(5):961-973. PubMed ID: 33849943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
